Clinical trials
Phase 1 Alzheimer Disease trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 3 |
| 2011 | 2 |
| 2012 | 2 |
| 2014 | 1 |
| 2016 | 2 |
| 2018 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wyeth is now a wholly owned subsidiary of Pfizer | 7 |
| University Hospital, Lille | 2 |
| University Hospital, Tours | 2 |
| Bristol-Myers Squibb | 1 |
| Eli Lilly and Company | 1 |
| Fondation Ophtalmologique Adolphe de Rothschild | 1 |
| Janssen Research & Development, LLC | 1 |
| Novartis Pharmaceuticals | 1 |
| Perha Pharmaceuticals | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 20 |
| Cognitive Dysfunction | 5 |
| Brain Diseases | 1 |
| Central Nervous System Diseases | 1 |
| Dementia | 1 |
| Down Syndrome | 1 |
| Memory Disorders | 1 |
| Nervous System Diseases | 1 |
| Neurocognitive Disorders | 1 |
| Neurodegenerative Diseases | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.